LeBar James 4
4 · Zomedica Pharmaceuticals Corp. · Filed Mar 17, 2020
Insider Transaction Report
Form 4
LeBar James
Director
Transactions
- Award
Stock Option (right to buy)
2020-03-13+200,000→ 200,000 totalExercise: $0.19Exp: 2025-03-13→ Common Shares, without par value (200,000 underlying)
Footnotes (1)
- [F1]The option vests in 4 equal annual installments commencing March 13, 2020.